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Adrenal chromaffin cells have been found to accumulate ascorbic acid by a saturable high affinity 
mechanism that is inhibited by hydrocortisone. The rate of ascorbic acid transport into cells was linear 
for at least 1 h and had a K, of 103 &I, a value approaching the reported concentration of ascorbic acid 
in the adrenal vein during stress. The uptake process itself, representing net accumulation rather than 
exchange, was inhibited by O”C, lack of sodium, ouabain, and by dinitrophenol and iodoacetate. 
Hydrocortisone but not the inactive analogue hydrocortisone hemisuccinate was found to inhibit ascorbic 
acid uptake in a reversible manner, with an ZDss of 62 pM. This value was within the reported steroid 
concentration in the adrenal portal system during a significant stress. Both ascorbic acid and 
hydrocortisone are secreted from cortical cells during stress into the adrenal portal system and thus contact 
medullary chromaffin cells. We suggest that the control of ascorbic acid uptake by hydrocortisone 
indicates the existence of a heretofore unanticipated biochemical aspect of the adrenal stress response. 
Ascorbic acid Hydrocortisone 
1. INTRODUCTION 
During stress, ACTH activates the adrenal cor- 
tex to release stored ascorbic acid and subsequently 
to release newly synthesized corticosteroids [ 1,2]. 
Both substances enter the adrenal sinusoids, which 
serve as a portal system supplying the chromaffin 
cells of the medulla [3,4]. The medulla also con- 
tains a substantial amount of ascorbic acid [S&l, 
raising the questions of whether ascorbate in the 
portal system might be transported by chromaffin 
cells, and whether corticosteroids might regulate 
this process. An ascorbate transport system has 
been indicated in [7,8]. We now report that ascor- 
bic acid is transported into chromaffin cells in a 
concentration dependent manner, and that the cor- 
ticosteroid hydrocortisone reversibly inhibits 
ascorbic acid uptake. We suggest hat ascorbic acid 
uptake into chromaffin cells and its regulation by 
corticosteroids may be an important and previous- 
ly unrecognized biochemical aspect of the adrenal 
response to stress. 
Chromaffin cell Transport 
2. MATERIALS AND METHODS 
2.1. Cell preparation and culture 
Chromaffin cells were prepared by collagenase 
digestion using a modification of the method in 
[9], as described [lo]. After preparation, the cells 
were incubated for 20 h in tissue culture flasks con- 
taining Basal Eagle Medium with Earle’s Salts 
(Gibco), supplemented with glutamine 2.93 mM, 
gentamicin 5 fig/ml, cytosine arabinoside 10 
pg/ml, streptomycin lOOpg/ml, and 5% fetal calf 
serum (Gibco). The cell concentration was 1 x 
1 06/ml medium. 
2.2. Assay of transport 
Cells in suspension culture were washed twice at 
room temperature by centrifugation and 
resuspended in a standard medium containing 118 
mM NaCl, 1.2 mM MgS04, 4.7 mM KCl, 10 mM 
glucose, 2.2 mM CaC12, and 25 mM HEPES- 
buffer (pH 7.4) with the addition of 0.1% bovine 
serum albumin (Calbiochem). The experiments 
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were initiated by adding cells to reaction mixtures 
prewarmed to 37°C. The reaction mixtures con- 
sisted of cells at 1 .O x 106/mol in 10 ml containing 
(~)-[14C]ascorbic acid (1 $XmI), 2.0 mM 
thiourea [11,121 standard medium and 0.1% final 
cont. bovine serum albumin. 
Cell aliquots (400 /tl) were withdrawn at dif- 
ferent times with an EM1 pipettor and blunt 16 
gauge needles and pipetted into polypropylene 
tubes (Selectopette tips, Becton Dickson Co.) that 
had been heat sealed at the bottom. The tubes each 
contained 0.4 ml of a 1:2 mixture of Ficoll Hypa- 
que and standard medium which was preshaken to 
the bottom of the tubes. The celI ahquots were 
pipetted l-2 cm above this shelf, with an air space 
between the 2 layers, and the tubes cooled on ice 
until the end of the time course. The tubes were 
then spun in an RC-2 Sorvall Centrifuge at 2600 
rev./min at 0°C for 5 min and frozen in an 
ethanol-dry ice mixture. The ends of the tubes 
containing the cell pellets and radioactive ascor- 
bate were cut with an offset snips, dissolved in 0.5 
ml protosol (New England Nuclear) and counted in 
a liquid scintillation counter. 
2.3. HPLC Anu~ys~ 
HPLC analysis of ascorbic acid was performed 
on a 5 gm radial compression Cl8 column using an 
ultraviolet detector at 254 nm (Waters). The 
mobile phase was 0.2% dicyclohexylamine phos- 
phate at 3.0 ml/min and 1500 lb/in2. @)-Ascorbic 
acid eluted at 6.0 min. 
Cells incubated with (R)-[14C]ascorbic acid for 2 
h were washed, lysed with water and centrifuged at 
30000 x g for 10 min. Supernatant samples, 
which contained 99% of the total celI homogenate 
radioactivity, were directly injected and fractions 
collected at 1 min intervals for determination of 
radioactivity. More than 95’Yo of the collected 
counts corresponded to the ascorbic acid peak. 
2.4. Chemicals and assays 
Protein was determined by Bradford Assays as 
described by this laboratory for application to 
chromaffin tissue [13]. Catecholamines were 
analyzed by the spectrofluorometric method 1141. 
Chemicals were reagent grade. R-[‘4C]Ascorbic 
acid was purchased from New England Nuclear 
(spec. act. 7.6 mCi/mmol). 
3. RESULTS 
3.1. Transport of ascorbic acid by cbromaf~n 
ceils 
(R)-[‘4C]Ascorbic acid was transported into 
chromaffin ceils in a linear fashion for nearly 1 h 
at 37*C (fig. 1A). In addition the uptake of (R)- 
[r4C]ascorbic a id was found to be dependent on 
ascorbic acid concentration i a saturable manner, 
exhibiting a Km of 103 PM (fig. 1B). To evaluate 
the stability of labelled ascorbic acid in cells, 
supernatants of water-lysed cell homogenates were 
analyzed by high-performance liquid chromato- 
graphy. More than 95% of the counts collected 
corresponded to the ascorbic acid peak (not 
shown). Thus, we concluded that R-[‘4C]-ascorbic 
acid was indeed transported by chromaffin cells, 
that transport was concentration dependent, and 
that the transported radiolabelled marker remain- 
ed as ascorbic acid. 
We then determined whether the transported 
ascorbic acid was free inside the cells, or bound. 
Cells that had been exposed to (R)-[14C]ascorbic 
acid were lysed in water. Under these conditions, 
96% of the label was released into the soluble frac- 
tion of the cell homogenate (table 1). Furthermore, 
when this soluble fraction was analyzed by ultra- 
filtration, we found that any possible site of ascor- 
bate binding was 5 10 kDa. By contrast, Dounce 
homogenization of labelled cells in an isotonic 
medium revealed that 14% of the total label was 
contained in a particulate but osmotically labile 
fraction which also contained >90% of the 
catecholamines, presumably in chromaffin 
granules. Since chromaffin granules are known to 
contain ascorbic acid [15], the data indicated that 
under these incubation conditions ascorbic acidin 
the cytoplasm had access to the granule pool. 
However, most of the labdled newly transported 
ascorbic acid remained in a non-segmenting 
cytoplasmic ompartment. 
3.2. Ascorbate transport leads to net 
accumulation by cells 
The uptake of ascorbic acid in chromaffln cells 
appeared to involve net accumulation rather than 
simple exchange, as shown in a direct analysis by 
HPLC (table 2). Cells incubated in 200 pM (R)- 
ascorbic acid for 3 h contained 8-fold more ascor- 
bic acid than cells without ascorbate in the 
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Fig. 1A. Uptake of (R)-[r4C]ascorbic acid into chromaf- 
fin cells as a function of time; ascorbic acid was 132,~M. 
Fig. 1B. Uptake of (R)-[14C]ascorbic acid into chromaf- 
fin cells as a function of varying concentrations of ascor- 
bic acid: (0) 164/rM; (A) 214/rM; (v) 314pM; (0) 614 
PM. Inset: Lineweaver-Burk plot of data in fig. 2; K,,, 
was 103 &l. 
medium. Furthermore, by estimating cell volume 
using a chroniaffin cell diameter of 18 pm, we 
calculated a maximum spherical cell volume and a 
minimum intracellular ascorbate concentration. 
Ascorbate in the loaded cells was at least 1.8 mM, 
compared with 200 PM in the incubation medium 
(table 2). The data therefore suggested that the 
mechanism of ascorbic acid transport involved a 
concentrative mechanism. 
3.3. Energetics of ascorbic acid transport 
As anticipated from studies of ascorbic acid 
transport in other systems [11,12,16], the uptake 
process in chromaffin cells was blocked at O”C, by 
metabolic inhibitors, and by lack of sodium. Oua- 
bain inhibited transport by 50%, and replacement 
of NaCl by choline also resulted in a 50% reduc- 
tion of transport. Dinitrophenol in combination 
with iodoacetate also inhibited uptake by 75% (not 
shown). 
Table 1 
Percent of (R)-[14C]ascorbic acid in supematants of 
disrupted cells 
Disruption method 
Water lysis 
Dounce homogenization 
in isotonic medium 
Centri- Ultra- 
fugation filtration 
95.5 f 3.1 91.4 f 6.7 
86.3 -t 9.5 80.3 f 13.3 
Chromaffin cells were incubated with (R)-[14C]ascorbic 
acid for 2 h. They were then washed twice and were 
either lysed in 10 vol. water or passed in a Dounce 
homogenizer in isotonic standard medium. The lysate 
and homogenate were each subjected to centrifugation 
of 30000 X g for 30 min or ultrafiltration, using an A4, 
10000 retention filter (Millipore). Percentages represent 
the percent of total cpm for each fraction remaining in 
the supernatant or filtrate; n = 3 
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Table 2 A 
Ascorbic acid accumulation in chromaffin cells 
Cells incubated Cells incubated with 
with no ascorbic 200 CM ascorbic 
(N = 4) acid for 3 h 
(N = 6) 
pg/106 cells 0.12 f 0.02 0.97 f 0.11 
mM 0.22 f 0.04 1.80 f 0.20 
Chromaffin cells were incubated with (R)-ascorbic acid 
as described and washed 3 times. Cells (1 vol.) were then 
extracted in chloroform: methanol 2~1, v/v) and the 
aqueous phase acidified to pH 3.5 prior to HPLC 
analysis. The amount of ascorbic acid accumulated by 
cells was identical whether ascorbic acid was radiolabell- 
ed or unlabelled (not shown). Cell volume was calculated 
using both a cell diameter of 18 pM and a spherical 
model, and thus ascorbate concentrations reflect 
B 
minimum values 
3.4. Influence of corticosteroids on ascorbic acid 
transport 
Because of the sequential nature of ascorbic acid 
and corticosteroid secretion in the adrenal gland 
]17,1gl, we investigated the ability of corti- 
costeroids to regulate ascorbic acid uptake. Hydro- 
cortisone, the bovine physiological glucocorticoid, 
was found to inhibit ascorbic acid transport into 
chromaffin cells in a dose-dependent manner (fig. 
2A). By contrast, hydrocortisone-21 -sodium 
hemisuccinate, a water-soluble derivative which 
must be hydrolyzed to be active, had no activity 
over lo-500 pM. A detailed analysis of the 
hydrocortisone effect (fig. 2B) indicated that the 
steroid exhibited over 90% of its inhibitory poten- 
cy over 2 log doses. In different experiments the 
IDSO ranged from 50-62 pM, which is in the 
physiological range for corticosteroids in the 
adrenal portal system under conditions of stress 
[17-191. 
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Fig. 2A. Corticosteroid inhibition of (R)-[r4C]ascorbic 
acid uptake in chromaffin cells: (0) hydrocortisone 50 
/tM; (0) hydrocortisone 250 ,uM; (v) hydrocortisone 
21-sodium hemi-succinate at 10 FM, 50 /tM and 200 CM 
also show no inhibition of ascorbic acid uptake (not 
We further reasoned that if hydrocortisone in- 
hibition of ascorbic acid uptake were of 
physiological significance, then the inhibition 
ought to be reversible. Indeed, when chromaffin 
cells were exposed to hydrocortisone for 1 h and 
washed twice in steroid-free medium, full ascorbic 
acid transport activity was restored. In addition, 
re-introduction of hydrocortisone to the washed 
cells resulted in prompt and complete inhibition of 
Fig. 2B. Hydrocortisone inhibition of (Z?)-[r4C]ascorbic 
acid uptake in chromaffin cells as a function of 
hydrocortisone concentration. Velocity data points, 
each representing 8 values, were determined by measur- 
ing (R)-[r4C]ascorbic acid uptake over 64 min at 16 min 
intervals, in the presence of the appropriate hydrocor- 
tisone concentration; ascorbate was 132 /tM. 
transport again (not shown). The ready reversibili- 
ty of the process as well as the effective concentra- 
tion range of the steroid indicated to us that we 
could be analyzing a physiologically relevant 
process. 
16 32 48 
MINUTES 
shown). 
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4. DISCUSSION REFERENCES 
These data demonstrate that ascorbic acid is ac- 
cumulated and concentrated in cultured bovine 
chromaffin cells by a saturable mechanism that is 
reversibly sensitive to physiological levels of 
hydrocortisone. It is therefore possible that this 
process is part of the adrenal stress response. 
However, the exact role of ascorbic acid in the 
adrenal stress response has remained an unsolved 
puzzle. Historically, it has been appreciated that 
the mammalian adrenal cortex and medulla con- 
tain the highest levels of ascorbic acid per mg pro- 
tein of any tissue [6,20]. It has also been ap- 
preciated that when ACTH stimulates the cortex 
during stress, 50% of cortical ascorbic acid is _ _. _ __.~__ -__.....--- ~-m<.. _._ -. 
released peripherally [1,2,17,18]. This means, of 
course, that the chromaffin cells are the first cells 
the newly released ascorbic acid reaches as it 
travels through the adrenal portal system. Thus, 
the chromaffin cells might initially accumulate 
ascorbate by the mech~sm we have described. 
Subsequently, newly synthesized hydrocortisone 
secreted from the adrenal cortex would reach local 
concentrations in the medulla [ 17- 191 which could 
then regulate ascorbic acid uptake. The ascorbic 
acid initially available for transport into chromaf- 
fin cells of the medulla would therefore become 
biochemically shunted to the general circulation. 
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